MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1021/acs.jmedchem.6c01970

Медицинская библиотека · Journal of medicinal chemistry · 2026

Targeting Transcriptional Coactivators p300/CBP: Small-Molecule Inhibitors or Bifunctional Proximity-Inducing Modalities?

Chen Zonglong, Huang Xun, Li Yingxia

СтатьяОбзорПеревод пока не подготовлен

Аннотация

p300 and its paralog CBP are multifunctional transcriptional coactivators that play central roles in epigenetic regulation by integrating diverse signaling pathways. Dysregulation of p300/CBP is closely linked to cancer and other diseases, rendering them attractive therapeutic targets. Several small-molecule inhibitors of p300/CBP, including CCS1477 and FT-7051, have advanced into clinical trials for cancer treatment. In this perspective, we provide a comprehensive overview of small-molecule inhibitors targeting the bromodomain and catalytic domain of p300/CBP, with particular emphasis on their optimization processes. Furthermore, the landscape of p300/CBP-targeted drug discovery has evolved from conventional inhibitors to sophisticated bifunctional proximity-inducing modalities. We discuss the transformative impact of bifunctional molecules targeting p300/CBP, including PROTACs, AceTAGs, RIPTACs, DALTACs, and TCIPs. Finally, we discuss current limitations and challenges and offer perspectives on future directions. This perspective aims to provide a strategic roadmap for the development of next-generation therapeutics targeting p300/CBP.

Для цитирования: Chen Zonglong, Huang Xun, Li Yingxia. Targeting Transcriptional Coactivators p300/CBP: Small-Molecule Inhibitors or Bifunctional Proximity-Inducing Modalities?. Journal of medicinal chemistry. 2026. DOI: 10.1021/acs.jmedchem.6c01970.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.